Upgrade to SI Premium - Free Trial

Werewolf Therapeutics (HOWL)

0.35 -0.15 (30.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (Posted A/C)

Latest Headlines

Werewolf Therapeutics, Inc. (HOWL) Tops Q2 EPS by 36c July 31, 2026 7:14 AM - StreetInsider Form 10-Q Werewolf Therapeutics, For: Jun 30 July 31, 2026 7:11 AM - SEC Filing Form 8-K Werewolf Therapeutics, For: Jul 31 July 31, 2026 7:06 AM - SEC Filing Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates July 31, 2026 7:00 AM - Globe NewsWire Form 4 Werewolf Therapeutics, For: Jul 06 Filed by: EVNIN LUKE July 8, 2026 5:34 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ONCOLOGY INNOVATIONS FUND LP July 6, 2026 5:20 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM Asset Management Investors BV2014 LLC July 6, 2026 5:19 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ASSET MANAGEMENT LLC July 6, 2026 5:19 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: UBS Oncology Impact Fund L.P. July 6, 2026 5:19 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014 (B), L.P. July 6, 2026 5:19 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P. July 6, 2026 5:18 PM - SEC Filing Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. July 2, 2026 8:27 PM - SEC Filing Form 4 Werewolf Therapeutics, For: Jun 29 Filed by: EVNIN LUKE June 29, 2026 7:07 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ONCOLOGY INNOVATIONS FUND LP June 29, 2026 5:30 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM Asset Management Investors BV2014 LLC June 29, 2026 5:30 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ASSET MANAGEMENT LLC June 29, 2026 5:30 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: UBS Oncology Impact Fund L.P. June 29, 2026 5:30 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014 (B), L.P. June 29, 2026 5:30 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P. June 29, 2026 5:29 PM - SEC Filing Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. June 26, 2026 5:39 PM - SEC Filing Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. June 22, 2026 7:02 PM - SEC Filing Form 4 Werewolf Therapeutics, For: Jun 17 Filed by: Kolchinsky Peter June 22, 2026 6:59 PM - SEC Filing Form 4 Werewolf Therapeutics, For: Jun 12 Filed by: Kolchinsky Peter June 16, 2026 6:01 PM - SEC Filing Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. June 15, 2026 8:16 PM - SEC Filing Form 4 Werewolf Therapeutics, For: Jun 09 Filed by: RA Capital Healthcare Fund LP June 11, 2026 8:14 PM - SEC Filing Form 4 Werewolf Therapeutics, For: Jun 09 Filed by: EVNIN LUKE June 10, 2026 5:21 PM - SEC Filing Form 4 Werewolf Therapeutics, For: Jun 04 Filed by: EVNIN LUKE June 8, 2026 6:13 PM - SEC Filing Form 4 Werewolf Therapeutics, For: Jun 01 Filed by: EVNIN LUKE June 3, 2026 6:43 PM - SEC Filing Form 4 Werewolf Therapeutics, For: May 27 Filed by: EVNIN LUKE May 29, 2026 6:52 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P. May 28, 2026 5:50 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: UBS Oncology Impact Fund L.P. May 28, 2026 5:50 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014 (B), L.P. May 28, 2026 5:50 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM Asset Management Investors BV2014 LLC May 28, 2026 5:50 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ASSET MANAGEMENT LLC May 28, 2026 5:50 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ONCOLOGY INNOVATIONS FUND LP May 28, 2026 5:50 PM - SEC Filing Form 4 Werewolf Therapeutics, For: May 21 Filed by: EVNIN LUKE May 26, 2026 6:18 PM - SEC Filing Form 4 Werewolf Therapeutics, For: May 18 Filed by: EVNIN LUKE May 20, 2026 6:09 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ONCOLOGY INNOVATIONS FUND LP May 18, 2026 5:03 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P. May 18, 2026 5:03 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014 (B), L.P. May 18, 2026 5:03 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: UBS Oncology Impact Fund L.P. May 18, 2026 5:02 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ASSET MANAGEMENT LLC May 18, 2026 5:02 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM Asset Management Investors BV2014 LLC May 18, 2026 5:01 PM - SEC Filing Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. May 14, 2026 5:24 PM - SEC Filing Form 4 Werewolf Therapeutics, For: May 13 Filed by: EVNIN LUKE May 13, 2026 4:07 PM - SEC Filing Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P. May 12, 2026 7:56 PM - SEC Filing Form 4 Werewolf Therapeutics, For: May 08 Filed by: EVNIN LUKE May 12, 2026 7:48 PM - SEC Filing Form 4 Werewolf Therapeutics, For: May 08 Filed by: Kolchinsky Peter May 12, 2026 6:26 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ONCOLOGY INNOVATIONS FUND LP May 11, 2026 4:34 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM ASSET MANAGEMENT LLC May 11, 2026 4:34 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P. May 11, 2026 4:34 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014 (B), L.P. May 11, 2026 4:34 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: UBS Oncology Impact Fund L.P. May 11, 2026 4:34 PM - SEC Filing Form 144 Werewolf Therapeutics, Filed by: MPM Asset Management Investors BV2014 LLC May 11, 2026 4:33 PM - SEC Filing Form 4 Werewolf Therapeutics, For: May 05 Filed by: EVNIN LUKE May 7, 2026 6:22 PM - SEC Filing Werewolf Therapeutics, Inc. (HOWL) Misses Q1 EPS by 1c May 7, 2026 4:26 PM - StreetInsider Form 10-Q Werewolf Therapeutics, For: Mar 31 May 7, 2026 4:18 PM - SEC Filing Form 8-K Werewolf Therapeutics, For: May 07 May 7, 2026 4:14 PM - SEC Filing Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates May 7, 2026 4:05 PM - Globe NewsWire Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P. May 5, 2026 7:04 PM - SEC Filing Form 4 Werewolf Therapeutics, For: Apr 30 Filed by: EVNIN LUKE May 4, 2026 6:00 PM - SEC Filing Full Article List